Literature DB >> 31445105

Amino acid changes in HA and determinants of pathogenicity associated with influenza virus A H1N1pdm09 during the winter seasons 2015-2016 and 2016-2017 in Mexico.

Joel Armando Vázquez-Pérez1, Daniela De La Rosa-Zamboni2, Ángel Emmanuel Vega-Sánchez3, Luis Horacio Gutiérrez-González3, Norma Angélica Téllez-Navarrete3, Fernando Campos3, Cristóbal Guadarrama-Pérez3, José Luis Sandoval3, Manuel Castillejos-López3, Rodolfo Norberto Jiménez-Juárez2, José Luis Sánchez-Huerta2, Brenda Berenice Pérez-Méndez2, Rogelio Pérez-Padilla3.   

Abstract

Biennial H1N1pdm09 influenza A virus (IAV) epidemics have been associated with major severity of respiratory disease in Mexico. Atypically and in contrast with what happened in USA, Canada and Europe during 2017, an increase of infections due to the H1N1pdm09 pandemic virus instead of H3N2 was observed. In order to determine the viral contribution to severe acute respiratory disease, we characterized the pathogenicity determinants of IAV in Mexico during the 2015-2016 and 2016-2017 seasons. The RNA segments of 20 IAV samples were sequenced by NGS platform and phylogenetic analysis was conducted. The analysis of the hemagglutinin (HA) sequences established that all virus samples, except one, belong to clade (6B.1). The IAVs presented the substitution S162 N, which introduces a new glycosylation site in the hemagglutinin. We also found the D222 G substitution, which has been associated with a higher tropism towards the lower respiratory tract, and a non-reported insertion of one Ile in NS1 (Ile113). The IAVs from 2016 to 2017 in Mexico belong to the new clade 6B.1. The new glycosylation site in HA (S162 N) is a major change that may affect the efficacy of the current vaccine. We detected in several patients pathogenicity determinants associated with the severity of the respiratory disease.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AH1N1pdm09; Influenza virus; Molecular determinants; Pathogenicity

Mesh:

Substances:

Year:  2019        PMID: 31445105     DOI: 10.1016/j.virusres.2019.197731

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  3 in total

1.  Mutation in Hemagglutinin Antigenic Sites in Influenza A pH1N1 Viruses from 2015-2019 in the United States Mountain West, Europe, and the Northern Hemisphere.

Authors:  Craig H Decker; Naomi Rapier-Sharman; Brett E Pickett
Journal:  Genes (Basel)       Date:  2022-05-19       Impact factor: 4.141

Review 2.  Development and application of reverse genetic technology for the influenza virus.

Authors:  Ziquan Li; Liping Zhong; Jian He; Yong Huang; Yongxiang Zhao
Journal:  Virus Genes       Date:  2021-02-02       Impact factor: 2.332

3.  Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib ameliorates influenza-virus-induced pneumonia in mice.

Authors:  Wei Liu; Xiaojuan Ren; Qian Wang; Yan Zhang; Junfeng Du
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-08-31       Impact factor: 3.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.